Glucocorticoids are currently used to treat chronic inflammatory disorders such as asthma, COPD, and rheumatoid arthritis. However, many chronic inflammatory disorders, such as pulmonary fibrosis, atherosclerosis-related diseases, chronic laryngitis, and chronic muscle injury, are immune to glucocorticoids. The therapeutic capacity of glucocorticoid steroids has been exhausted, necessitating the development of new anti-inflammatory drugs or therapies. Moxa (Artemisia Argyi) is a plant that produces anti-inflammatory smoke or tar when burned. Based on some clinical trials and the author's personal observation, the author wants to present a new way (moxa tar) of treating glucocorticoid steroid resistant chronic inflammatory diseases in this article. The aim of this article is to introduce a new area and to draw researchers' attention to it in order to develop new anti-inflammatory drugs or therapies. The researchers used a crossover design in this study, in which patients act as their own controls, comparing clinical symptoms and signs before and after moxa tar treatment.
Author (s) DetailsQian Zeng
Medi7 Clinic Bentleigh, Australia.
View Book :- https://stm.bookpi.org/CDHR-V7/article/view/916
No comments:
Post a Comment